Buys
Open market- Shares
- +3,000
- Avg price
- $14.40
- Total value
- +$43,200
Nelson Sun - Chief Financial & Operating Officer at Aardvark Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial & Operating Officer
- Issuer ticker
- AARD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Nelson Sun in Aardvark Therapeutics, Inc.
Sells
Open market- Shares
- -76,754
- Avg price
- $5.15
- Total value
- -$394,957
Net
Past year- Shares
- -73,754
- Share %
- -92%
- Total value
- -$351,757
Reported holdings for Nelson Sun in Aardvark Therapeutics, Inc.
Form 4 holding
Chief Financial & Operating Officer
Aardvark Therapeutics, Inc.
- Security class
- Common Stock, par value $0.00001 per share
- Shares / value
- 35,475
- Estimated value
- $183,771
- Report date
- 11 Sep 2026
- Price
- $5.18
- Ownership
- Direct
Form 4 holding
Chief Financial & Operating Officer
Aardvark Therapeutics, Inc.
- Security class
- Stock option (right to buy)
- Shares / value
- 70,549
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial & Operating Officer
Aardvark Therapeutics, Inc.
- Security class
- Series C Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 14 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Nelson Sun in Aardvark Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.